,

NDFS12 – BARDA Presentation: CARB-X: A Novel Non-Dilutive Partnership to Promote Innovation and Foster a Robust Antimicrobials Pipeline

Tyler Merkeley of the Biomedical Advanced Research and Development Authority (BARDA) CARB-X program talks about the novel non-dilutive partnership created to promote innovation and foster a robust antimicrobials pipeline.

 

View Slide Deck

/0 Comments/by
You might also like
NDFS17 InflammatixNDFS17 Video: Inflammatix: Our Road to Success with Non-Dilutive Funding
NDFS13 NIH Presentation: Overview and Update on HHS SBIR/STTR Programs
R&DMoneyView Unveiling at the 11th Annual Non-Dilutive Funding Summit
BARDA Coronavirus Countermeasures Portfolio
NDFS13 Life Science Nation Presentation: The 10 Myths of Fundraising
National Institute on Aging (NIA) Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Armineh GhazarianNIA at NDFS 2023, with Dr. Armineh Ghazarian
Diassess Awarded Up to $21.9M from BARDA
BARDA at NDFS
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *